Trauma-related hypotension and coagulopathy worsen secondary brain injury in patients with traumatic brain injuries (TBIs). Early damage control resuscitation with blood products may mitigate hypotension and coagulopathy. Preliminary data suggest resuscitation with plasma in large animals improves neurologic function after TBI; however, data in humans are lacking.
T raumatic brain injuries (TBIs) represent approximately one third of all injury-related deaths in civilian settings. 1 Although mortality after TBI has improved, 1,2 poor neurologic outcomes continue to result in a significant burden for patients, their families, health systems, and society. [3] [4] [5] Resuscitation of patients with TBIs is primarily focused on maintenance of hemodynamics to prevent secondary brain injury as hypoxemia and hypotension are independent predictors of worse outcomes. 6 Large animal data suggest that the early resuscitation with plasma in combined TBI and hemorrhagic shock models may improve neurologic outcomes. [7] [8] [9] [10] To address these gaps in our TBI resuscitation approach, studies are underway evaluating crystalloid versus blood products in patients with hemorrhagic shock and TBI. 11, 12 More study is needed regarding the effects of coagulopathy and TBI in patients with multisystem trauma. 13 The goal of prehospital resuscitation in hypotensive TBI patients is to support oxygen delivery and restore cerebral perfusion. 6 Previous work demonstrated that early use of packed red blood cells (pRBCs) using remote damage control resuscitation techniques was associated with improved outcomes in severely injured trauma patients. [14] [15] [16] [17] [18] [19] [20] Recent literature in favor of balanced massive transfusion protocols (equal parts pRBCs, plasma, and platelets) led to the use of thawed plasma in prehospital damage control resuscitation at limited centers. 14, 19, 21 However, because of limited data on hypotensive TBI patients with multiple injuries, the current Brain Trauma Foundation guidelines continue to recommend resuscitation with crystalloid or colloid in the prehospital setting. 6 These guidelines still recommend maintaining a systolic blood pressure of >90 mm Hg but do not comment on the ideal fluid.
Previous research has suggested that 30-day survival was significantly improved in TBI patients with multiple injuries undergoing massive transfusion with a high fresh frozen plasma to pRBC ratios. 22 With improvements in mortality, the focus of resuscitation must also consider improving neurologic outcomes given that the debility from long-term neurologic damage can be significant. 23 To investigate neurologic outcomes, Halaweish et al. evaluated differing resuscitation protocols and determined a plasma-based resuscitation approach was associated with improved cognitive function and reduced neurologic severity in swine. 10 In an effort to determine whether this benefit in swine translates to humans, we analyzed our experience with prehospital damage control resuscitation practices in hypotensive TBI patients with multiple injuries. Because patients with multisystem trauma and TBI incur significant debility, it was our aim to determine whether a difference existed in neurologic and functional outcomes in patients receiving either thawed plasma or pRBCs in the prehospital setting. We hypothesized that in hypotensive TBI patients with multiple injuries not on anticoagulation, remote damage control resuscitation with exclusively thawed plasma would have improved neurologic outcomes at dismissal and during short-term follow-up when compared to resuscitation with exclusively pRBCs.
METHODS

Patient Cohort
After obtaining institutional review board approval, a prospectively maintained database of all trauma patients undergoing prehospital transfusion at a single rural Level I trauma center from January 2002 to December 2013 was retrospectively reviewed. All patients aged 15 years or older who presented with a diagnosis of hypotension, TBI, and received either exclusively thawed plasma or exclusively pRBCs alone in the prehospital setting were identified and screened against inclusion and exclusion criteria (Fig. 1) . All patients were transported by critical care rotor wing transport teams.
Institutional Protocol
The remote damage control blood transfusion protocol is initiated when patients meet criteria based on an institutional critical care transport guidelines ( Fig. 1) and is given to patients with evidence of hemorrhagic shock and hemodynamic instability or when reversal of international normalized ratio (INR) is necessary.
14 Our institution began transfusing pRBCs in the prehospital setting in 1988 and thawed plasma in February of 2009. 16 Currently, thawed plasma is transfused first and then the units are alternated between pRBCs and thawed plasma in patients with hemodynamic instability. Patients were transfused based on our adult prehospital transfusion guideline 14 (Fig. 4) .
Inclusion Criteria
The presence of multisystem trauma was defined as an Injury Severity Score (ISS) >9. Patients were identified as having a TBI if they had head Abbreviated Injury Score (AIS) ≥2. Patients transferred from another hospital were included if transported by rotor wing.
Exclusion Criteria
Patients with a history of anticoagulation or antiplatelet medications were excluded. Patients who died before dismissal were also excluded as our study was designed to focus on long-term neurologic outcomes. Patients transported via ground were also excluded given that the ground crews generally do not carry blood products. Lastly, patients who received mixed prehospital transfusions in the prehospital setting (both thawed plasma and pRBCs) were excluded to evaluate the effect of thawed plasma and pRBCs alone. We also excluded patients with a head AIS of 1 and 6 so that TBI was reflected in the degree of head injury.
Primary and Secondary Outcomes
The primary outcomes of Glasgow Outcome Score Extended (GOSE) and Disability Rating Scale (DRS) were calculated at dismissal and during follow-up visits. The GOSE categorizes a patient's disability 24 and is measured on a scale from 1 to 8, with 1 meaning death and 8 describing a high functioning individual. DRS measures generalized functional changes during recovery. 25 The DRS is measured on a scale from 1 to 29 with various intervals correlating with the degree of dysfunction at a given time; therefore, a higher score reflects increased dysfunction. Outcomes utilizing GOSE and DRS scores were assessed as follows: categorical values (unfavorable) were assigned for GOSE less than 6 and DRS greater than 7 for patients to be considered for decreased functional outcome. 26 Favorable outcomes were assigned as a GOSE ≥6 and DRS ≤7. Scores were retrospectively calculated based on physical medicine and rehabilitation, neurology, and physical/occupational therapist providers and throughout the patients' follow-up rehabilitation period. Follow-up analysis included patients with GOSE and DRS assessments between 4 and 8 months after dismissal.
Secondary predictors included duration of stay, type and number of transfused units given in prehospital and in hospital setting, massive transfusion administration, critical administration threshold status, 27 hospital duration of stay, prehospital transportation duration, scene versus inter-facility transfer, emergency room vital signs, laboratories obtained at admission, trauma center arrival Glasgow Coma Scale (GCS), Injury Severity Score (ISS), radiologic diagnosis of intracranial pathology (multifocal intracranial hemorrhage, epidural hemorrhage, subarachnoid hemorrhage, subdural hemorrhage, intraparenchymal hemorrhage, and diffuse axonal injury), and head AIS.
Statistical Analyses
Patients who received exclusively thawed plasma were compared to those who received exclusively pRBCs in the prehospital environment via our institution's remote damage control resuscitation protocol.
14 Summary univariate comparisons were performed. Independent variables were analyzed to determine their associations with improved neurocognitive function with Disability Rating Scale and Glasgow Outcome Score Extended. These variables included patient age, gender, severity of TBI, head AIS, GCS, head injury diagnosis, ISS, laboratory values on arrival to the emergency department (ED) including hemoglobin, INR, lactate, admission blood alcohol level, thromboelastography, emergency room vital signs, the number of units of prehospital blood product given, and total volume of prehospital crystalloid administered. Univariate analysis evaluated the aforementioned variables' associations with GOSE and DRS.
Continuous variables were described using means with standard deviations if normally distributed and medians with interquartile ranges (IQRs) for non-normally distributed data, and two-tailed t tests or Wilcoxon rank sum tests were performed to compare patient and injury factors between plasma and pRBC groups. Categorical variables were summarized as proportions, and differences were evaluated using χ 2 tests or Fisher's exact tests when appropriate.
To confirm that observed differences in outcomes between plasma and pRBC groups were not caused by confounding factors that affected the likelihood of a patient to receive one treatment or the other, a propensity score for receiving plasma was developed using age, ISS, and GCS, which were deemed to be most clinically relevant to assigning treatment type. Multivariable logistic regression models assessed the relationship between treatment type and neurologic outcomes after adjusting for the logit transformation of the propensity score. Model results are reported as odds ratios (ORs) and 95% confidence intervals (CIs), and model fit was assessed with area under the curve (AUC). All p values were considered significant at p < 0.05. Data were analyzed with JMP (SAS Institute, Inc., Cary, NC) and SAS version 9.4 (SAS Institute, Inc., Cary, NC). We utilized GraphPad Prism (GraphPad Software, Inc., La Jolla, CA) for all visual graphics.
RESULTS
After applying inclusion and exclusion criteria (Fig. 2) , we identified a total of 76 subjects. Sensitivity analysis was performed comparing in-hospital mortality in the plasma group to those in the pRBC group and no significant difference in mortality rate between transfusion groups plasma (16%) and pRBC (23%, p = 0.32). Mean age was 53.6 ± 25 years and 61.8% were men. Overall, the median ISS [IQR] was 24 [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] , and median head AIS score was 3 [2] [3] [4] [5] . No patients experienced transfusionrelated adverse reactions as identified by transfusion-related lung injury, febrile transfusion reactions, hemolytic reactions, anaphylaxis, or transfusion-associated circulatory overload.
There was no significant difference in patient age, gender, severity of TBI, head AIS, GCS, head injury diagnosis, ISS, laboratory values on arrival to the ED including hemoglobin, INR, lactate, the number of units of prehospital blood product given, and total volume of prehospital crystalloid administered or length of stay (all p > 0.05, Table 1 ). The indications for transfusion were hypotension (n = 76, 100%) and tachycardia (n = 76, 100%) as noted in prehospital medical records.
There were no significant differences between the transportation time of each patient between thawed plasma (median 26.5 ) minutes and pRBC (median 26 [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] ) minutes.
Twenty-five patients (33%) received massive transfusion protocol and 13 (17%) met critical administration threshold for pRBC administration. With regard to inpatient blood product administration, there was no significant difference between the prehospital thawed plasma and pRBC groups (p > 0.05, Fig. 3 ). Among prehospital transfusion groups, there were no significant differences between inter-facility transfers between (thawed plasma n = 12 vs. pRBCs n = 14, p = 0.53) and scene transfer (n = 24 vs. n = 26, p = 0.8).
Neurologic Outcomes
Improved functional neurologic outcomes at dismissal (Fig. 4) , demonstrated by a higher median [IQR] GOSE, was seen in patients receiving plasma (7 [7] [8] ) compared to those receiving pRBCs (5.5 [3] [4] [5] [6] [7] , p < 0.001). Utilizing median [IQR] DRS scores at dismissal also demonstrated improved outcomes in patients who received thawed plasma (2 [1-3.5]) compared to pRBCs (9 [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] , p < 0.001). These improvements in neurologic outcomes as assessed by the GOSE and DRS scores reflect a prehospital resuscitation with thawed plasma as opposed to pRBCs. Among the 54 patients with neurologic assessments during the follow-up period (median 6 [5] [6] [7] months, Fig. 4) , the improvements seen at dismissal persisted in patients resuscitated with thawed plasma compared to pRBCs. Table 2 highlights the differences of unfavorable and favorable classification of GOSE and DRS scores between prehospital transfusion strategies (thawed plasma vs. pRBCs). Table 2 also demonstrates these categorical differences by increasing head AIS. Patients with increased unfavorable neurologic and functional outcomes (GOSE <6 or DRS >7) were associated with prehospital pRBC transfusion. After adjusting for propensity at dismissal compared to patients in the pRBC resuscitation group. The very low number of events (n = 5 for unfavorable GOSE and n = 8 for unfavorable DRS) at follow-up precluded performing similar multivariable analysis on the follow-up neurologic outcome measures.
Review of CT head imaging demonstrated the following findings: multifocal hemorrhage (n = 20, 26%), intraparenchymal hemorrhage (n = 16, 21%), subarachnoid hemorrhage (n = 16, 21%), subdural hemorrhage (n = 20, 26%), epidural hemorrhage (n = 1, 2%), and diffuse axonal injury (n = 3, 4%). Nearly half of all patients had progressive hemorrhagic injury as diagnosed by a board-certified radiologist using head CT (n = 37, 49%). Six patients required craniectomy and n = 18 (24%) required intracranial pressure monitoring.
DISCUSSION
Analysis of this highly selected group of trauma patients demonstrated that prehospital damage control resuscitation with plasma is associated with improved neurologic outcomes compared to resuscitation with pRBCs alone in hypotensive TBI patients with multiple injuries. This is the first retrospective analysis comparing the neurologic functional outcome of patients with multisystem trauma and TBI with either plasma or pRBCs alone. Specifically, greater GOSE and lower DRS scores were seen in patients receiving plasma. This suggests that both neurologic and functional outcomes may be improved with the early use of plasma. These findings support recent large animal studies 8, 10 and highlight the need for further prospective research to ensure optimized neurologic outcomes in trauma patients with TBI. The current guidelines recommend using isotonic fluids to maintain perfusion; however, supporting data are conflicting. 6 Retrospective studies have demonstrated improved survival for TBI patients with multiple injuries receiving a high fresh frozen plasma/pRBC resuscitation. 18, 22 The mechanism behind this survival benefit is likely related to acute traumatic coagulopathy (ATC), which may affect TBI patients with multiple injuries. 28, 29 For patients with TBI and ATC, the activation of protein C systematically via the endothelia may be a mediator driving hypotension in affected patients. 29 ATC is multifactorial state of activated, dynamic, leaky endothelia worsened by hypotension and, potentially, crystalloid resuscitation. 30 It is believed that this coagulopathy occurs early after trauma, and thus early resuscitation aimed at correcting the coagulopathy may improve outcomes. 31, 32 In the setting of TBI and hemodynamic instability, high-volume crystalloid resuscitation may increase cerebral edema and secondary brain injury. 30 Resuscitation with a colloid fluid composed of coagulation factors and fibrinogen, like plasma, may mitigate the early effects of ATC and thus potentially prevent secondary neurologic dysfunction in TBI patients with multiple injuries. 33 The preliminary finding that improved neurologic outcomes at patient dismissal are associated with the use of prehospital plasma transfusion is a crucial first step toward the identification of an ideal resuscitative fluid in hypotensive TBI patients with multiple injuries. The potential benefit is twofold. First, plasma may be used as the initial fluid in damage control resuscitation for hemodynamic instability to provide necessary volume. Replenishing this volume with plasma may be a better adjunct than pRBCs and the ideal first step to a balanced and neurocognitive protective resuscitation. Second, the association of improved functional and neurocognitive outcomes via early use of plasma may be an additional indication given the disparate outcomes of severe TBI in patients with multiple injuries. Although it is unknown what the exact mechanism is caused by the complex nature of the fluid, it is increasingly an important adjunct in trauma resuscitation and its incorporation into TBI research may have increased therapeutic potential. Additionally, our data support the theory that the replacement of coagulation factors promotes increased neuroprotective genetic transcription to reduce brain lesion size and swelling, and this mechanism may be associated with the improved neurologic function of this patient cohort. 34 As the prehospital and inpatient care of patients with TBI continues to improve, further research should be given to the study of prehospital blood product administration and type. Evaluation of the ongoing studies will provide an important foundation for transfusion strategies. 11, 12 These studies may identify or posit additional questions for the determination of the optimal plasma/blood transfusion ratio in patients with hemorrhagic shock and TBI. Future translational directions could also potentially incorporate various drugs with properties to potentially remove neurotoxins or promote stabilization of the blood-brain barrier with plasma administration for the optimal prevention of secondary brain injury and improve neurocognitive function. Moreover, the feasibility and the efficacy of lyophilized plasma will need to be addressed as well.
Limitations
The present study has a number of limitations related to the retrospective nature of the study design and highly selected cohort. The highly selective study inclusion and exclusion criteria diminish generalizability, but it is necessary for answering our hypothesis. In addition, the exclusion of patients who died before dismissal, despite being similar in both groups, may result in survival bias; however, functional outcomes are not applicable to these patients. Our institution has administered blood product in transport beginning in 1988; therefore, we were Although DRS is a validated scoring system, it can become insensitive at measuring differences of function at the low (more functional) end of the TBI spectrum. Lastly, our limited sample size prevented us from conducting subgroup analyses or utilizing propensity scores. However, these findings suggest that a prospective multi-institutional study to determine the ideal resuscitation fluid in TBI patients with multiple injuries is warranted.
CONCLUSION
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